Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Emkay Global Financial's research report on ICICI Lombard
ICICIGI is well on track to achieve 102% CoR by FY25E; its shares have run up ~25% (vs NIFTY50 up ~0%) post good Q3FY24 results. Recent outperformance of ICICI shares appears to be fully pricing-in improved operational performance and optimism of: i) no near-term headwind for GI on the Regulatory front; ii) minimum ~0.8% stake purchase by ICICI Bank before 9-Sep-24; iii) material improvement in CoR and EPS on Ind-AS implementation starting Apr-25. But we also see challenges: 1) likelihood of no hike in Motor TP tariffs causing lower industry growth and worsening of combined ratio in the TP segment; 2) prospect of greater intensity in Motor OD and Retail Health to drive higher distribution payouts and pressure on pricing, in pursuit of growth by smaller players; 3) price revision-led growth moderating in the Health segment.
Outlook
Against this backdrop, we marginally revise our FY24-26 estimates, leading to ~1-2% cut in GWP, ~0.4ppt increase in CoR and ~3-4% cut in EPS for FY25-26E. We downgrade the stock to REDUCE from Add, with Mar-25E TP of Rs1,650 (vs. Dec-24E TP of Rs1,600 earlier), implying 28x FY26E P/E and 5.2x FY26E P/B.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!